Shopping Cart
- Remove All
Your shopping cart is currently empty
BCX 1470 methanesulfonate inhibits the esterolytic activity of factor D and C1s (IC50: 96 nM and 1.6 nM), exhibiting 3.4- and 200-fold greater efficacy than trypsin, respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,080 | 1-2 weeks | |
| 50 mg | $1,410 | 1-2 weeks | |
| 100 mg | $2,140 | 1-2 weeks |
| Description | BCX 1470 methanesulfonate inhibits the esterolytic activity of factor D and C1s (IC50: 96 nM and 1.6 nM), exhibiting 3.4- and 200-fold greater efficacy than trypsin, respectively. |
| Targets&IC50 | C1s:1.6 nM , Trypsin:326 nM , FD:96 nM |
| In vitro | BCX 1470 methanesulfonate is an inhibitor serine protease. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro. |
| In vivo | BCX 1470 methanesulfonate blocked the development of RPA-induced edema in the rat. |
| Molecular Weight | 398.48 |
| Formula | C15H14N2O5S3 |
| Cas No. | 217099-44-0 |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 33.33 mg/mL (83.64 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.